New York, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Healthcare Interoperability Solutions Industry" - https://www.reportlinker.com/p06031760/?utm_source=GNW
-Online interactive peer-to-peer collaborative bespoke updates
-Access to our digital archives and MarketGlass Research Platform
-Complimentary updates for one year
Global Healthcare Interoperability Solutions Market to Reach US$4.4 Billion by the Year 2026
Interoperability in the healthcare sector has risen considerably in the past few years. The market expansion is triggered by implementation of healthcare IT interoperability regulations in various countries. Government agencies in countries like the US have made it mandatory for healthcare organizations to comply with interoperability guidelines. Factors such as policy requirements and governmental regulations are creating strong demand for data integration and analytics systems. These factors are pushing the uptake of healthcare IT applications and slated to benefit providers of healthcare interoperability systems. Ongoing shift towards value-base patient care along with emergence of innovative healthcare delivery models is expected to boost adoption of healthcare interoperability systems. The demand for these solutions is also propelled by the need to ensure connectivity of medical devices and systems through the care continuum. The market is likely to receive a major impetus from increasing uptake of app integration, application programming interface integration, data integration, data cleansing, data interoperability and data analytics solutions. The EHR Incentive Programs have been renamed Promoting Interoperability and the 21st Century Cures Act. Seamless and safe exchange of information across the healthcare ecosystem will facilitate digital health achieving its optimal potential.
Amid the COVID-19 crisis, the global market for Healthcare Interoperability Solutions estimated at US$2.1 Billion in the year 2020, is projected to reach a revised size of US$4.4 Billion by 2026, growing at a CAGR of 12.4% over the analysis period. Services, one of the segments analyzed in the report, is projected to grow at a 13.4% CAGR to reach US$2.8 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Software segment is readjusted to a revised 11% CAGR for the next 7-year period. This segment currently accounts for a 45.1% share of the global Healthcare Interoperability Solutions market. The global market is led by the services segment owing to increasing transition of healthcare facilities towards cloud-based platforms and cloud computing. The move enables users to reduce operating costs and improve performance of various processes and applications. Growth in the software segment is due to increasing requirement for seamless access to patient data coupled with adoption of healthcare IT solutions for quality care delivery and enhanced patient satisfaction.
The U.S. Market is Estimated at $1.2 Billion in 2021, While China is Forecast to Reach $187.7 Million by 2026
The Healthcare Interoperability Solutions market in the U.S. is estimated at US$1.2 Billion in the year 2021. The country currently accounts for a 51.94% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$187.7 Million in the year 2026 trailing a CAGR of 18.6% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.7% and 11.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11% CAGR while Rest of European market (as defined in the study) will reach US$203.9 Million by the end of the analysis period. North America retains the imposing position in the healthcare interoperability solutions market and accounts for the majority stake due to increasing demand for quality and efficient healthcare delivery along with the pressing requirement to curb healthcare expenditure. The market growth is fueled by rising implementation of EHR across healthcare organizations. Future expansion of the regional market is poised to be favored by favorable regulations and initiatives to improve efficiency of the healthcare system. The market in Asia-Pacific region is buoyed by high burden on the healthcare system that requires advanced interoperability solutions to increase the efficiency and productivity.
Select Competitors (Total 68 Featured) -
- Allscripts Healthcare, LLC
- Cerner Corporation
- EMIS Health
- Epic Systems Corporation
- Infor (US), Inc.
- Interfaceware® Inc.
- InterSystems Corporation
- Jitterbit, Inc.
- Koninklijke Philips N.V.
- NXGN Management, LLC
- Orion Health Group Limited
- OSP Labs
- ViSolve Inc.
Read the full report: https://www.reportlinker.com/p06031760/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Healthcare Interoperability Solutions - Global Key Competitors
Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
A Prelude to Healthcare Interoperability Solutions
Barriers to Healthcare Interoperability
Merits of Healthcare Interoperability
Impact of Covid-19 and a Looming Global Recession
2020: A Year of Disruption & Transformation
As the Race between the Virus & Vaccines Intensifies, Where is
the World Economy Headed
World Economic Growth Projections (Real GDP, Annual % Change)
for 2020 through 2022
COVID-19 Pandemic Provides Impetus to Healthcare
Interoperability Solutions
Importance of Healthcare Interoperability Picks up Momentum in
the Covid-19 Era
Global Market Overview and Prospects
Global Healthcare Interoperability Solutions Market to Glimmer
with Robust Health
Drivers Pushing Healthcare Interoperability Market Forward into
Bright Future
Services Segment Claims Dominating Share
Diagnosis Dominates Applications Category
Hospitals Remain Primary End-Use Segment
North America Sways Healthcare Interoperability Solutions
Market with Majority Stake
Competitive Scenario
New Product Launch & Portfolio Expansion: Strategies to Stay
Competitive in Healthcare Interoperability Solutions Market
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS AND DRIVERS
Salient Factors with Pivotal Role in Shift towards Healthcare
Interoperability
Focus on Patient-Centered Care Delivery Highlights the Growing
Need for Interoperability
Sharp Rise in Clinical Data Volume and Streamlining Imaging
Workflow Present Lucrative Growth Opportunities
Growing Patient Volume, Data Privacy Concerns and Need for
Accuracy in Data Management Drive Market Demand
Increasing Complexity of Healthcare Operations to Spur Demand
for Healthcare Interoperability Solutions
Global Healthcare IT Market (2020): Percentage Breakdown of
Spending by Sector
Large Installation Base of EHR Systems Drives the Need for EHR
Interoperability
Factors Triggering Adoption of EHR
Rise in Integration of Disruptive Technologies in EHR
EHR Interoperability and Associated Issues
Digitalization of Healthcare and Technological Advancements
Digital Health Investments Record Strong Growth
Digital Health Funding (in US$ billion): 2015-2020
Healthcare System’s Expedited Shift towards Telemedicine Spurs
Opportunity for Healthcare Interoperability Solutions
Global Number of Telemedicine Patients (In Million) for the
Years 2016, 2018, 2020, 2023 & 2025
COVID-19 Outbreak Accelerates Broader Use of Telemedicine
Telemedicine Leads Digital Health Investments Driven by Covid-
19: Leading Categories of Digital Health by Funding (In US$
Million) for the Year 2020
Telehealth Visits in the U.S (In Million) for the Year 2020
COVID-19 Drives Prominence of Healthcare Analytics
Importance of Sharing Healthcare Data Picks up Momentum in the
Covid-19 Era
The Move to Cloud Gains Momentum
Cloud-based EHR Systems
Rise in Funding to Driving Market Expansion
Increasing Usage of Smart Devices Augments the Need for Data
Interoperability
Smartphone Penetration Rate as Share of Total Population: 2016-
2021
Increasing Deployment of Smart Devices Across Healthcare
Augments the Need for Data Interoperability
IoMT: The New Healthcare ?Tech’ Evolution
Global IoT Market (In US$ Billion) by Industry for the Years
2018 and 2022
Number of Connected Medical Devices in Million: 2018-2025
Healthcare IT Market Enjoys Striking Leap Forward with
Increasing Influx of IoT
Big Data Analytics Playing a Pivotal Role in Healthcare
Global Healthcare Data Generated: 2014, 2020, and 2025
(in exabytes)
Rising Need to Reduce Healthcare Costs to Propel Demand for
Healthcare Interoperability Solutions
Use of EHRs and HIEs to Cut Down Healthcare Costs
ECDOH’s Approach
Current & Required Healthcare Spending as % of GDP
World Healthcare Expenditure (In US$ Billion) for the Years
2017-2023
Rapidly Aging World Population & COVID-19 Induced Re-Focus on
Aging-In-Place to Drive Demand
Aging Population Steps-Up The Burden on Healthcare: Global
Aging Population Statistics for the 65+ Age Group in Million
by Geographic Region for the Years 2019, 2025, 2035 and 2050
Interoperability Challenges and Solutions
The Route to Improving Healthcare Interoperability
Transitioning to Advanced Data Infrastructures
Enforcing New Industry Standards
Supporting and Updating Systems
Regulations for Interoperability Standards Drive Market Growth
Information Blocking Final Rule
Interoperability and Patient Access Final Rule (CMS-9115-F)
Interoperability and Prior Authorization Final Rule (CMS-9123-F)
US Updates Regulatory Regime with New Rules
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Services by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Services by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR
Table 3: World 15-Year Perspective for Services by Geographic
Region - Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 4: World Recent Past, Current & Future Analysis for
Software by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 5: World Historic Review for Software by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR
Table 6: World 15-Year Perspective for Software by Geographic
Region - Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 7: World Recent Past, Current & Future Analysis for
Diagnosis by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 8: World Historic Review for Diagnosis by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR
Table 9: World 15-Year Perspective for Diagnosis by Geographic
Region - Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 10: World Recent Past, Current & Future Analysis for
Treatment by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 11: World Historic Review for Treatment by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR
Table 12: World 15-Year Perspective for Treatment by Geographic
Region - Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 13: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 14: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 16: World Recent Past, Current & Future Analysis for
Hospitals by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 17: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR
Table 18: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 19: World Recent Past, Current & Future Analysis for
Ambulatory Surgical Centers by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Revenues in
US$ Thousand for Years 2020 through 2027 and % CAGR
Table 20: World Historic Review for Ambulatory Surgical Centers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 21: World 15-Year Perspective for Ambulatory Surgical
Centers by Geographic Region - Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027
Table 22: World Recent Past, Current & Future Analysis for
Other End-Uses by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 23: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 24: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 25: World Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 26: World Historic Review for Healthcare Interoperability
Solutions by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 27: World 15-Year Perspective for Healthcare
Interoperability Solutions by Geographic Region - Percentage
Breakdown of Value Revenues for USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
Healthcare Interoperability Solutions Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United States
for 2022 (E)
Table 28: USA Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by Type - Services and
Software - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 29: USA Historic Review for Healthcare Interoperability
Solutions by Type - Services and Software Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR
Table 30: USA 15-Year Perspective for Healthcare
Interoperability Solutions by Type - Percentage Breakdown of
Value Revenues for Services and Software for the Years 2012,
2021 & 2027
Table 31: USA Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by Application -
Diagnosis, Treatment and Other Applications - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 32: USA Historic Review for Healthcare Interoperability
Solutions by Application - Diagnosis, Treatment and Other
Applications Markets - Independent Analysis of Annual Revenues
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 33: USA 15-Year Perspective for Healthcare
Interoperability Solutions by Application - Percentage
Breakdown of Value Revenues for Diagnosis, Treatment and Other
Applications for the Years 2012, 2021 & 2027
Table 34: USA Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by End-Use - Hospitals,
Ambulatory Surgical Centers and Other End-Uses - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 35: USA Historic Review for Healthcare Interoperability
Solutions by End-Use - Hospitals, Ambulatory Surgical Centers
and Other End-Uses Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 36: USA 15-Year Perspective for Healthcare
Interoperability Solutions by End-Use - Percentage Breakdown of
Value Revenues for Hospitals, Ambulatory Surgical Centers and
Other End-Uses for the Years 2012, 2021 & 2027
CANADA
Table 37: Canada Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by Type - Services and
Software - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 38: Canada Historic Review for Healthcare
Interoperability Solutions by Type - Services and Software
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 39: Canada 15-Year Perspective for Healthcare
Interoperability Solutions by Type - Percentage Breakdown of
Value Revenues for Services and Software for the Years 2012,
2021 & 2027
Table 40: Canada Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by Application -
Diagnosis, Treatment and Other Applications - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 41: Canada Historic Review for Healthcare
Interoperability Solutions by Application - Diagnosis,
Treatment and Other Applications Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR
Table 42: Canada 15-Year Perspective for Healthcare
Interoperability Solutions by Application - Percentage
Breakdown of Value Revenues for Diagnosis, Treatment and Other
Applications for the Years 2012, 2021 & 2027
Table 43: Canada Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by End-Use - Hospitals,
Ambulatory Surgical Centers and Other End-Uses - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 44: Canada Historic Review for Healthcare
Interoperability Solutions by End-Use - Hospitals, Ambulatory
Surgical Centers and Other End-Uses Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR
Table 45: Canada 15-Year Perspective for Healthcare
Interoperability Solutions by End-Use - Percentage Breakdown of
Value Revenues for Hospitals, Ambulatory Surgical Centers and
Other End-Uses for the Years 2012, 2021 & 2027
JAPAN
Healthcare Interoperability Solutions Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Table 46: Japan Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by Type - Services and
Software - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 47: Japan Historic Review for Healthcare Interoperability
Solutions by Type - Services and Software Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR
Table 48: Japan 15-Year Perspective for Healthcare
Interoperability Solutions by Type - Percentage Breakdown of
Value Revenues for Services and Software for the Years 2012,
2021 & 2027
Table 49: Japan Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by Application -
Diagnosis, Treatment and Other Applications - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 50: Japan Historic Review for Healthcare Interoperability
Solutions by Application - Diagnosis, Treatment and Other
Applications Markets - Independent Analysis of Annual Revenues
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 51: Japan 15-Year Perspective for Healthcare
Interoperability Solutions by Application - Percentage
Breakdown of Value Revenues for Diagnosis, Treatment and Other
Applications for the Years 2012, 2021 & 2027
Table 52: Japan Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by End-Use - Hospitals,
Ambulatory Surgical Centers and Other End-Uses - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 53: Japan Historic Review for Healthcare Interoperability
Solutions by End-Use - Hospitals, Ambulatory Surgical Centers
and Other End-Uses Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 54: Japan 15-Year Perspective for Healthcare
Interoperability Solutions by End-Use - Percentage Breakdown of
Value Revenues for Hospitals, Ambulatory Surgical Centers and
Other End-Uses for the Years 2012, 2021 & 2027
CHINA
Healthcare Interoperability Solutions Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in China for 2022 (E)
Table 55: China Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by Type - Services and
Software - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 56: China Historic Review for Healthcare Interoperability
Solutions by Type - Services and Software Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR
Table 57: China 15-Year Perspective for Healthcare
Interoperability Solutions by Type - Percentage Breakdown of
Value Revenues for Services and Software for the Years 2012,
2021 & 2027
Table 58: China Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by Application -
Diagnosis, Treatment and Other Applications - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 59: China Historic Review for Healthcare Interoperability
Solutions by Application - Diagnosis, Treatment and Other
Applications Markets - Independent Analysis of Annual Revenues
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 60: China 15-Year Perspective for Healthcare
Interoperability Solutions by Application - Percentage
Breakdown of Value Revenues for Diagnosis, Treatment and Other
Applications for the Years 2012, 2021 & 2027
Table 61: China Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by End-Use - Hospitals,
Ambulatory Surgical Centers and Other End-Uses - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 62: China Historic Review for Healthcare Interoperability
Solutions by End-Use - Hospitals, Ambulatory Surgical Centers
and Other End-Uses Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 63: China 15-Year Perspective for Healthcare
Interoperability Solutions by End-Use - Percentage Breakdown of
Value Revenues for Hospitals, Ambulatory Surgical Centers and
Other End-Uses for the Years 2012, 2021 & 2027
EUROPE
Healthcare Interoperability Solutions Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Table 64: Europe Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by Type - Services and
Software - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 65: Europe Historic Review for Healthcare
Interoperability Solutions by Type - Services and Software
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 66: Europe 15-Year Perspective for Healthcare
Interoperability Solutions by Type - Percentage Breakdown of
Value Revenues for Services and Software for the Years 2012,
2021 & 2027
Table 67: Europe Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by Application -
Diagnosis, Treatment and Other Applications - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 68: Europe Historic Review for Healthcare
Interoperability Solutions by Application - Diagnosis,
Treatment and Other Applications Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR
Table 69: Europe 15-Year Perspective for Healthcare
Interoperability Solutions by Application - Percentage
Breakdown of Value Revenues for Diagnosis, Treatment and Other
Applications for the Years 2012, 2021 & 2027
Table 70: Europe Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by End-Use - Hospitals,
Ambulatory Surgical Centers and Other End-Uses - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 71: Europe Historic Review for Healthcare
Interoperability Solutions by End-Use - Hospitals, Ambulatory
Surgical Centers and Other End-Uses Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR
Table 72: Europe 15-Year Perspective for Healthcare
Interoperability Solutions by End-Use - Percentage Breakdown of
Value Revenues for Hospitals, Ambulatory Surgical Centers and
Other End-Uses for the Years 2012, 2021 & 2027
Table 73: Europe Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by Geographic Region -
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 74: Europe Historic Review for Healthcare
Interoperability Solutions by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 75: Europe 15-Year Perspective for Healthcare
Interoperability Solutions by Geographic Region - Percentage
Breakdown of Value Revenues for France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets for Years 2012, 2021 &
2027
FRANCE
Healthcare Interoperability Solutions Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in France for 2022 (E)
Table 76: France Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by Type - Services and
Software - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 77: France Historic Review for Healthcare
Interoperability Solutions by Type - Services and Software
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 78: France 15-Year Perspective for Healthcare
Interoperability Solutions by Type - Percentage Breakdown of
Value Revenues for Services and Software for the Years 2012,
2021 & 2027
Table 79: France Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by Application -
Diagnosis, Treatment and Other Applications - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 80: France Historic Review for Healthcare
Interoperability Solutions by Application - Diagnosis,
Treatment and Other Applications Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR
Table 81: France 15-Year Perspective for Healthcare
Interoperability Solutions by Application - Percentage
Breakdown of Value Revenues for Diagnosis, Treatment and Other
Applications for the Years 2012, 2021 & 2027
Table 82: France Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by End-Use - Hospitals,
Ambulatory Surgical Centers and Other End-Uses - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 83: France Historic Review for Healthcare
Interoperability Solutions by End-Use - Hospitals, Ambulatory
Surgical Centers and Other End-Uses Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR
Table 84: France 15-Year Perspective for Healthcare
Interoperability Solutions by End-Use - Percentage Breakdown of
Value Revenues for Hospitals, Ambulatory Surgical Centers and
Other End-Uses for the Years 2012, 2021 & 2027
GERMANY
Healthcare Interoperability Solutions Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Germany for 2022:
(E)
Table 85: Germany Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by Type - Services and
Software - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 86: Germany Historic Review for Healthcare
Interoperability Solutions by Type - Services and Software
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 87: Germany 15-Year Perspective for Healthcare
Interoperability Solutions by Type - Percentage Breakdown of
Value Revenues for Services and Software for the Years 2012,
2021 & 2027
Table 88: Germany Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by Application -
Diagnosis, Treatment and Other Applications - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 89: Germany Historic Review for Healthcare
Interoperability Solutions by Application - Diagnosis,
Treatment and Other Applications Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR
Table 90: Germany 15-Year Perspective for Healthcare
Interoperability Solutions by Application - Percentage
Breakdown of Value Revenues for Diagnosis, Treatment and Other
Applications for the Years 2012, 2021 & 2027
Table 91: Germany Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by End-Use - Hospitals,
Ambulatory Surgical Centers and Other End-Uses - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 92: Germany Historic Review for Healthcare
Interoperability Solutions by End-Use - Hospitals, Ambulatory
Surgical Centers and Other End-Uses Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR
Table 93: Germany 15-Year Perspective for Healthcare
Interoperability Solutions by End-Use - Percentage Breakdown of
Value Revenues for Hospitals, Ambulatory Surgical Centers and
Other End-Uses for the Years 2012, 2021 & 2027
ITALY
Table 94: Italy Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by Type - Services and
Software - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 95: Italy Historic Review for Healthcare Interoperability
Solutions by Type - Services and Software Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR
Table 96: Italy 15-Year Perspective for Healthcare
Interoperability Solutions by Type - Percentage Breakdown of
Value Revenues for Services and Software for the Years 2012,
2021 & 2027
Table 97: Italy Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by Application -
Diagnosis, Treatment and Other Applications - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 98: Italy Historic Review for Healthcare Interoperability
Solutions by Application - Diagnosis, Treatment and Other
Applications Markets - Independent Analysis of Annual Revenues
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 99: Italy 15-Year Perspective for Healthcare
Interoperability Solutions by Application - Percentage
Breakdown of Value Revenues for Diagnosis, Treatment and Other
Applications for the Years 2012, 2021 & 2027
Table 100: Italy Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by End-Use - Hospitals,
Ambulatory Surgical Centers and Other End-Uses - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 101: Italy Historic Review for Healthcare
Interoperability Solutions by End-Use - Hospitals, Ambulatory
Surgical Centers and Other End-Uses Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR
Table 102: Italy 15-Year Perspective for Healthcare
Interoperability Solutions by End-Use - Percentage Breakdown of
Value Revenues for Hospitals, Ambulatory Surgical Centers and
Other End-Uses for the Years 2012, 2021 & 2027
UNITED KINGDOM
Healthcare Interoperability Solutions Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United Kingdom
for 2022 (E)
Table 103: UK Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by Type - Services and
Software - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 104: UK Historic Review for Healthcare Interoperability
Solutions by Type - Services and Software Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR
Table 105: UK 15-Year Perspective for Healthcare
Interoperability Solutions by Type - Percentage Breakdown of
Value Revenues for Services and Software for the Years 2012,
2021 & 2027
Table 106: UK Recent Past, Current & Future Analysis for
Healthcare Interoperability Solutions by Application -
Diagnosis, Treatment and Other Applications - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 107: UK Historic Review for Healthcare Interoperability
Solutions by Application - Diagnosis, Treatment and Other
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06031760/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
